Rachel L. Tomko, M.S. - Publications

Psychology University of Missouri-Columbia, Columbia, MO 
Personality disorders

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 McClure EA, Wahlquist AE, Tomko RL, Baker NL, Carpenter MJ, Bradley ED, Cato PA, Gipson CD, Gray KM. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug and Alcohol Dependence. 225: 108815. PMID 34171822 DOI: 10.1016/j.drugalcdep.2021.108815  0.308
2020 Baker NL, Gray KM, Ramakrishnan V, Tomko RL, McClure EA, Carpenter MJ, Saladin ME. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addiction Biology. e12918. PMID 32476209 DOI: 10.1111/Adb.12918  0.315
2020 Carpenter RW, Squeglia LM, Emery NN, McClure EA, Gray KM, Miranda R, Tomko RL. Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline. Drug and Alcohol Dependence. 209: 107897. PMID 32058245 DOI: 10.1016/J.Drugalcdep.2020.107897  0.341
2019 Aguinaldo LD, Squeglia LM, Gray KM, Coronado C, Lees B, Tomko RL, Jacobus J. Behavioral Treatments for Adolescent Cannabis Use Disorder: a Rationale for Cognitive Retraining. Current Addiction Reports. 6: 437-442. PMID 32257767 DOI: 10.1007/S40429-019-00287-7  0.39
2019 Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Current Addiction Reports. 6: 429-436. PMID 32133273 DOI: 10.1007/S40429-019-00290-Y  0.334
2019 Tomko RL, Baker NL, Hood CO, Gilmore AK, McClure EA, Squeglia LM, McRae-Clark AL, Sonne SC, Gray KM. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology. PMID 31712969 DOI: 10.1007/S00213-019-05384-Z  0.434
2019 McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31612956 DOI: 10.1093/Ntr/Ntz170  0.364
2019 Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. Jama Pediatrics. PMID 31609433 DOI: 10.1001/Jamapediatrics.2019.3553  0.315
2019 Fadus MC, Squeglia LM, Valadez EA, Tomko RL, Bryant BE, Gray KM. Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies. Current Psychiatry Reports. 21: 96. PMID 31522280 DOI: 10.1007/S11920-019-1086-0  0.389
2019 Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addictive Behaviors. 98: 106052. PMID 31415971 DOI: 10.1016/J.Addbeh.2019.106052  0.317
2019 Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological Treatment of Youth Substance Use Disorders. Journal of Child and Adolescent Psychopharmacology. PMID 31009234 DOI: 10.1089/Cap.2019.0009  0.431
2019 Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug and Alcohol Dependence. 198: 105-111. PMID 30901744 DOI: 10.1016/J.Drugalcdep.2019.01.041  0.342
2019 Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Current Opinion in Psychology. 30: 35-41. PMID 30798020 DOI: 10.1016/J.Copsyc.2019.01.009  0.351
2019 Akbar SA, Tomko RL, Salazar CA, Squeglia LM, McClure EA. Tobacco and cannabis co-use and interrelatedness among adults. Addictive Behaviors. 90: 354-361. PMID 30522075 DOI: 10.1016/J.Addbeh.2018.11.036  0.35
2018 McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Experimental and Clinical Psychopharmacology. PMID 30556733 DOI: 10.1037/Pha0000244  0.354
2018 Tomko RL, Gilmore AK, Gray KM. Corrigendum to The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine Addictive Behaviors 85 (2018) 26-30. Addictive Behaviors. PMID 30268706 DOI: 10.1016/J.Addbeh.2018.09.023  0.399
2018 McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug and Alcohol Dependence. 192: 59-66. PMID 30218864 DOI: 10.1016/J.Drugalcdep.2018.07.018  0.343
2018 Tomko RL, Jones JL, Gilmore AK, Brady KT, Back SE, Gray KM. -acetylcysteine: A potential treatment for substance use disorders. Current Psychiatry. 17: 30-55. PMID 30016376  0.317
2018 Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. International Review of Psychiatry (Abingdon, England). 1-10. PMID 29956576 DOI: 10.1080/09540261.2018.1465398  0.333
2018 Bountress KE, Bacanu SA, Tomko RL, Korte KJ, Hicks T, Sheerin C, Lind MJ, Marraccini M, Nugent N, Amstadter AB. The Effects of a BDNF Val66Met Polymorphism on Posttraumatic Stress Disorder: A Meta-Analysis. Neuropsychobiology. 1-7. PMID 29874672 DOI: 10.1159/000489407  0.326
2018 Tomko RL, Gilmore AK, Gray KM. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addictive Behaviors. 85: 26-30. PMID 29803870 DOI: 10.1016/J.Addbeh.2018.05.014  0.333
2018 Tomko RL, McClure EA. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addictive Behaviors. PMID 29661656 DOI: 10.1016/J.Addbeh.2018.04.004  0.399
2018 Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. The American Journal of Drug and Alcohol Abuse. 1-16. PMID 29513609 DOI: 10.1080/00952990.2018.1437445  0.324
2018 Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug and Alcohol Dependence. 185: 17-22. PMID 29413434 DOI: 10.1016/J.Drugalcdep.2017.12.005  0.427
2017 Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, ... ... Tomko RL, et al. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and Alcohol Dependence. 177: 249-257. PMID 28623823 DOI: 10.1016/J.Drugalcdep.2017.04.020  0.378
2017 Clayton RB, Leshner G, Tomko RL, Trull TJ, Piasecki TM. Countering Craving with Disgust Images: Examining Nicotine Withdrawn Smokers' Motivated Message Processing of Anti-Tobacco Public Service Announcements. Journal of Health Communication. 22: 254-261. PMID 28248620 DOI: 10.1080/10810730.2016.1268222  0.522
2017 Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression. Journal of Clinical Medicine. 6. PMID 28098747 DOI: 10.3390/Jcm6010009  0.413
2016 Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology. PMID 27838746 DOI: 10.1007/S00213-016-4472-X  0.325
2016 Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addictive Behaviors. 63: 172-177. PMID 27521979 DOI: 10.1016/J.Addbeh.2016.08.001  0.342
2016 Tomko RL, Bountress KE, Gray KM. Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug and Alcohol Dependence. PMID 27515725 DOI: 10.1016/J.Drugalcdep.2016.07.022  0.359
2016 Tomko RL, Prisciandaro JJ, Falls SK, Magid V. The structure of the UPPS-R-Child impulsivity scale and its relations with substance use outcomes among treatment-seeking adolescents. Drug and Alcohol Dependence. PMID 26905208 DOI: 10.1016/J.Drugalcdep.2016.02.010  0.32
2016 Scheiderer EM, Wang T, Tomko RL, Wood PK, Trull TJ. Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder. Clinical Psychological Science : a Journal of the Association For Psychological Science. 4: 67-81. PMID 26904388 DOI: 10.1177/2167702615573214  0.614
2015 Bentzley JP, Tomko RL, Gray KM. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder. Journal of Substance Abuse Treatment. PMID 26827257 DOI: 10.1016/J.Jsat.2015.12.003  0.388
2015 Tomko RL, Lane SP, Pronove LM, Treloar HR, Brown WC, Solhan MB, Wood PK, Trull TJ. Undifferentiated Negative Affect and Impulsivity in Borderline Personality and Depressive Disorders: A Momentary Perspective. Journal of Abnormal Psychology. PMID 26147324 DOI: 10.1037/Abn0000064  0.595
2015 Tomko RL, Lane SP, Pronove LM, Treloar HR, Brown WC, Solhan MB, Wood PK, Trull TJ. Undifferentiated Negative Affect and Impulsivity in Borderline Personality and Depressive Disorders: A Momentary Perspective Journal of Abnormal Psychology. DOI: 10.1037/abn0000064  0.567
2014 Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. Journal of Personality Disorders. 28: 734-50. PMID 25248122 DOI: 10.1521/Pedi_2012_26_093  0.628
2014 Epler AJ, Tomko RL, Piasecki TM, Wood PK, Sher KJ, Shiffman S, Heath AC. Does hangover influence the time to next drink? An investigation using ecological momentary assessment. Alcoholism, Clinical and Experimental Research. 38: 1461-9. PMID 24588377 DOI: 10.1111/Acer.12386  0.326
2014 Tomko RL, Solhan MB, Carpenter RW, Brown WC, Jahng S, Wood PK, Trull TJ. Measuring impulsivity in daily life: the momentary impulsivity scale. Psychological Assessment. 26: 339-49. PMID 24274047 DOI: 10.1037/A0035083  0.583
2014 Brown WC, Tragesser SL, Tomko RL, Mehl MR, Trull TJ. Recall of expressed affect during naturalistically observed interpersonal events in those with borderline personality disorder or depressive disorder. Assessment. 21: 73-81. PMID 24056953 DOI: 10.1177/1073191113504618  0.606
2014 Tomko RL, Brown WC, Tragesser SL, Wood PK, Mehl MR, Trull TJ. Social context of anger in borderline personality disorder and depressive disorders: findings from a naturalistic observation study. Journal of Personality Disorders. 28: 434-48. PMID 22984859 DOI: 10.1521/Pedi_2012_26_064  0.614
2013 Carpenter RW, Tomko RL, Trull TJ, Boomsma DI. Gene-environment studies and borderline personality disorder: a review. Current Psychiatry Reports. 15: 336. PMID 23250817 DOI: 10.1007/S11920-012-0336-1  0.577
2011 Jahng S, Solhan MB, Tomko RL, Wood PK, Piasecki TM, Trull TJ. Affect and alcohol use: an ecological momentary assessment study of outpatients with borderline personality disorder. Journal of Abnormal Psychology. 120: 572-84. PMID 21823761 DOI: 10.1037/A0024686  0.603
2011 Jahng S, Trull TJ, Wood PK, Tragesser SL, Tomko R, Grant JD, Bucholz KK, Sher KJ. Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity. Journal of Abnormal Psychology. 120: 656-69. PMID 21604829 DOI: 10.1037/A0023539  0.576
2011 Talley AE, Tomko RL, Littlefield AK, Trull TJ, Sher KJ. The influence of general identity disturbance on reports of lifetime substance use disorders and related outcomes among sexual minority adults with a history of substance use. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 530-41. PMID 21480677 DOI: 10.1037/A0023022  0.533
2010 Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. Journal of Personality Disorders. 24: 412-26. PMID 20695803 DOI: 10.1521/Pedi.2010.24.4.412  0.596
2010 Tragesser SL, Solhan M, Brown WC, Tomko RL, Bagge C, Trull TJ. Longitudinal associations in borderline personality disorder features: Diagnostic Interview for Borderlines-Revised (DIB-R) scores over time. Journal of Personality Disorders. 24: 377-91. PMID 20545501 DOI: 10.1521/Pedi.2010.24.3.377  0.528
2010 Trull TJ, Tomko RL, Brown WC, Scheiderer EM. Borderline Personality Disorder in 3-D: Dimensions, Symptoms, and Measurement Challenges Social and Personality Psychology Compass. 4: 1057-1069. DOI: 10.1111/J.1751-9004.2010.00312.X  0.419
Show low-probability matches.